A rare cause of neonatal cholestasis: congenital portosystemic shunt

Neonatal cholestasis is a pathological condition characterized by impaired bile flow in infants, typically presenting within the first 3 months of life. While common etiologies include biliary atresia, metabolic disorders, and infections, rare causes such as congenital portosystemic shunts must also be considered in the differential diagnosis. We present the case of a term infant with a congenital portosystemic shunt who presented with cholestasis and hyperammonemia. Bilirubin and liver function enzymes gradually decreased after initiation of ursodeoxycholic acid therapy. In newborns presenting with hypoglycemia, cholestasis, and thrombocytopenia, initial investigations are usually performed for metabolic diseases, congenital infections (toxoplasmosis, cytomegalovirus, rubella, herpes simplex virus), and genetic causes. As these tests may take time to return, early radiological imaging should be pursued to evaluate for anatomical abnormalities.

Authors

Institutions

Publication Details

Journal
Baylor University Medical Center Proceedings
Published
2025-08-28
DOI
https://doi.org/10.1080/08998280.2025.2547338
Primary Topic
Pediatric Hepatobiliary Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A rare cause of neonatal cholestasis: congenital portosystemic shunt

Asuman Nur Karhan, Nezihe Köker, Seda Aydoğan, Hasibe Gökçe Çınar et al.
Baylor University Medical Center Proceedings
Pediatric Hepatobiliary Diseases and Treatments
article

A rare cause of neonatal cholestasis: congenital portosystemic shunt

Asuman Nur Karhan, Nezihe Köker, Seda Aydoğan, Hasibe Gökçe Çınar, Rıdvan Turhan
article en

Abstract

Neonatal cholestasis is a pathological condition characterized by impaired bile flow in infants, typically presenting within the first 3 months of life. While common etiologies include biliary atresia, metabolic disorders, and infections, rare causes such as congenital portosystemic shunts must also be considered in the differential diagnosis. We present the case of a term infant with a congenital portosystemic shunt who presented with cholestasis and hyperammonemia. Bilirubin and liver function enzymes gradually decreased after initiation of ursodeoxycholic acid therapy. In newborns presenting with hypoglycemia, cholestasis, and thrombocytopenia, initial investigations are usually performed for metabolic diseases, congenital infections (toxoplasmosis, cytomegalovirus, rubella, herpes simplex virus), and genetic causes. As these tests may take time to return, early radiological imaging should be pursued to evaluate for anatomical abnormalities.

Baylor University Medical Center ProceedingsVol. 38(6)
Inonu University (TR), Memorial Ankara Hospital (TR)
Zero hunger
Openalex Percentile: Top 64%
Pediatric Hepatobiliary Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A rare cause of neonatal cholestasis: congenital portosystemic shunt — Asuman Nur Karhan, Nezihe Köker, et al. · Baylor University Medical Center Proceedings (2025) | TGRS Research Map | TGRS